Leukemia Precision Diagnosis
At Fosun Health, diagnosing leukemia is not just about “finding cancer cells”—it is about understanding your unique blood cancer biology to design the most precise treatment plan. Our streamlined diagnostic pathway delivers answers within days, not weeks:
A standard complete blood count (CBC) can reveal abnormal levels of white blood cells, red blood cells, or platelets. If results are concerning, we move immediately to definitive testing.
This is the essential test for leukemia diagnosis. Using a thin needle, we take a small sample of bone marrow (usually from the hipbone) and examine it under a microscope. The procedure is done with local anesthesia and takes only minutes.
What we learn: Type of leukemia (ALL, AML, CLL, CML, etc.), percentage of blast cells, and cellular structure.
This technology analyzes the surface markers of leukemia cells to precisely classify the subtype. It helps distinguish acute from chronic, B-cell from T-cell, and guides initial therapy.
Using chromosome analysis (karyotype) and next-generation sequencing (NGS), we identify specific genetic mutations (e.g., BCR-ABL, FLT3, IDH1/2, NPM1, CEBPA, TP53) and chromosomal abnormalities (e.g., translocations, deletions). These findings determine prognosis and guide targeted therapy, immunotherapy (e.g., CAR-T), or allogeneic stem cell transplantation.
